ZenaTech Completes Acquisition of Workplace Scheduling Software Company Othership Limited and Plans to Use Quantum Computing to Increase Productivity for Multinational Corporations
March 18, 2025
Technology
-
-
AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test
March 18, 2025
-
Valens Semiconductor Partners with Seven MIPI A-PHY Silicon Vendors, Successfully Completing Product Interoperability Testing to Advance the MIPI A-PHY Ecosystem in China and Globally
March 18, 2025
-
Gorilla Technology Named Exclusive AI & Digital Infrastructure Partner for $100B Global Edge Fund, Raises 2025 Revenue Guidance to $110M in Schwab Networks Interview
March 13, 2025
-
ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.
March 13, 2025
-
Scope Technologies Corp Announces Channel Partnership with COGITO to Expand Global Reach
March 13, 2025
-
Magnachip Introduces 25 New Gen6 SJ MOSFETS to Expand Power Product Lineup for AI, Industrial Applications and Smart Home Appliances
March 12, 2025
-
Premier Domestic Bank Expands Its Partnership with Intellicheck
March 11, 2025
-
Verb Unveils Telehealth Vertical in Partnership with Savannah Chrisley
March 11, 2025
-
H.I.G. Capital Completes Acquisition of Quisitive
March 11, 2025
-
Gorilla Technology Formally Launches Initial Phases of AI-Driven Energy Transformation Initiative
March 10, 2025
-
Research Solutions Launches Clearinghouse For AI Rights To Scientific Literature
March 10, 2025
-
SEALSQ Expands Global Reach with New Distribution and Sales Agreements Across Europe, Asia, and the Middle East
March 10, 2025
-
Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
March 6, 2025
-
ProStar and Point One Navigation Form a Strategic Partnership to Revolutionize Precision Mapping and Critical Asset Management Worldwide
March 6, 2025
-
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
March 6, 2025